Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines

Reuters2021-06-15

KUALA LUMPUR, June 15 (Reuters) - Malaysia's health ministry said on Tuesday it has granted conditional approval for emergency use to the single dose COVID-19 vaccines manufactured by China's CanSino Biologics and U.S. drugmaker Johnson&Johnson.

It has also approved the use of the Pfizer-BioNTech vaccine for recipients aged 12 and above, the ministry said in a statement.

(Reporting by Rozanna Latiff Editing by Ed Davies)

((rozanna.latiff@thomsonreuters.com; +61 3 9492 9423 ; Reuters Messaging: @rozlatiff on Twitter))

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法